Menarini Hires Their 17,000th Employee

Food and Healthcare Press Releases Tuesday March 13, 2018 12:34
FLORENCE, Italy--13 Mar--PRNewswire/InfoQuest
The 17,000th employee at Menarini is Lara, 28 years old, a young graduate in Chemistry and Pharmaceutical Technology from the University of Florence, who is now employed in Menarini Ricerche.
(Photo: https://mma.prnewswire.com/media/653104/Menarini_employees.jpg )
(Photo: https://mma.prnewswire.com/media/653105/Menarini_Group.jpg )
(Photo: https://mma.prnewswire.com/media/653106/Menarini_Lara_Tamantini.jpg )
(Logo: https://mma.prnewswire.com/media/652491/MENARINI_Group_Logo.jpg )

Menarini is present in 136 countries world-wide and continues to invest heavily in Italy: out of 17,000 Group employees, more than 3,700 work in Italy, almost 300 of whom were hired over the last two years and work in the Group's Florentine headquarters.

With an average age of 29, more than 90% of Menarini employees hold a degree or a technical diploma and cover highly qualified profiles.

"We are proud of this achievement," said Lucia Aleotti and Alberto Giovanni Aleotti, Chairman and Vice Chairman of the Menarini Group, "and take this opportunity to highlight how being able to hire the 17,000th staff member is largely due to the extraordinary work carried out by all our employees who, with enthusiasm and determination, are the true makers of the success of the Menarini Group."

With the opening of two new affiliates in Peru and Colombia, investments in the Berlin and Pisa research centers, and the growth of Asia Pacific, Menarini's strategy has always been focused on both the quality of their products and internationalization. Menarini closed the year 2017 with a turnover of 3.6 billion Euro.

About the Menarini Group

The Menarini Group is an Italian pharmaceutical company, 12th in Europe out of 5,255 companies, and 36th company in the world out of 20,862 companies, with a turnover of more than 3,5 billion Euro and more than 16,700 employees. The Menarini Group has always pursued two strategic objectives: Research and Internationalisation and is present in the most important therapeutic areas including products for cardiology, gastroenterology, pneumology/antibiotics, diabetology, anti-inflammatory agents/analgesics. With 16 production sites and 6 Research and Development centers, the Menarini Group has a strong presence throughout Europe and Asia, Africa, Central and South America. Menarini's products are available in 136 countries worldwide. For further information please visit http://www.menarini.com

Source: Menarini Group

Latest Press Release

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Related Topics